Oxadiazoles in Medicinal Chemistry
Jonas Boström(Universeum), Alleyn T. Plowright(AstraZeneca (Sweden)), Eric Wellner(AstraZeneca (Sweden)), Antonio Llinàs(AstraZeneca (Sweden)), Anders Hogner(AstraZeneca (Sweden))
Cited by 593
Related Papers
Analysis of Past and Present Synthetic Methodologies on Medicinal Chemistry: Where Have All the New Reactions Gone?
|Journal of Medicinal Chemistry|2015|2k
Expanding the medicinal chemistry synthetic toolbox
|Nature Reviews Drug Discovery|2018|693
Assessing the performance of OMEGA with respect to retrieving bioactive conformations
|Journal of Molecular Graphics and Modelling|2003|315
Conformational energy penalties of protein-bound ligands
|Journal of Computer-Aided Molecular Design|1998|246
Deep Reinforcement Learning for Multiparameter Optimization in <i>de novo</i> Drug Design
|Journal of Chemical Information and Modeling|2019|217